Professional Documents
Culture Documents
4807 Full
4807 Full
4807 Full
1,3
Department of Urologic Surgery, Vanderbilt University Medical Center; 2Department of Pathology, Vanderbilt
Childrens Hospital; and 3The Vanderbilt-Ingram Cancer Center, Nashville, Tennessee
Abstract
Cancer may arise from a cancer stem/progenitor cell that
shares characteristics with its normal counterpart. We report
the reconstitution of the original human prostate cancer
specimen from epithelial cell lines (termed HPET for human
prostate epithelial/hTERT) derived from this sample. These
tumors can be described in terms of Gleason score, a
classification not applied to any of the transgenic mouse
models currently developed to mimic human disease. Immunohistochemical and Western blot analyses indicate that they
do not express androgen receptor or p63, similar to that
reported for prostate stem cells. These cell lines also express
embryonic stem markers (Oct4, Nanog, and Sox2) as well as
early progenitor cell markers (CD44 and Nestin) in vitro.
Clonally derived HPET cells reconstitute the original human
tumor in vivo and differentiate into the three prostate
epithelial cell lineages, indicating that they arise from a
common stem/progenitor cell. Serial transplantation experiments reconstitute the tumors, suggesting that a fraction of
parental or clonally derived HPET cells have self-renewal
potential. Thus, this model may enhance our understanding of
human tumor development and provide a mechanism for
studying cancer stem/progenitor cells in differentiation,
tumorigenesis, preclinical testing, and the development of
drug resistance. [Cancer Res 2007;67(10):480715]
Introduction
Cancer stem cells are thought to arise from a multipotent stem
cell that has accumulated genetic alterations during its long life
span (1). An alternative hypothesis suggests that normal stem cell
differentiation may be arrested during cell determination and
differentiation, thereby affecting the development of malignant
potential (2). Cancer stem/progenitor cells may exhibit characteristics similar to normal stem cells. For example, stem cells express
the protein telomerase, which maintains telomere length and
facilitates continuous cell division (3). They divide and give rise to
multiple progenitor cell types that down-regulate telomerase
activity during gestation (4) and early cell passage in vitro (5).
Thus, loss of telomerase activity seems to limit the mitotic capacity
of progenitor cells. Roy et al. showed that hTERT-immortalized
progenitor cells from human fetal spinal cord sustained telomerase
www.aacrjournals.org
4807
Cancer Research
Supernatants were collected 48 h after transfection, filter sterilized, and
stored at 80jC. All procedures were done as recommended by Vanderbilt
University safety regulations for Lentivirus usage.
Establishment of HPET cell lines. Radical retropubic prostatectomy
specimens were obtained in compliance with the laws and institutional
guidelines approved by the Institutional Review Board Committee of
Vanderbilt University. Prostate tissues were processed, and HPE cells were
cultured and maintained as described previously (12). Briefly, punch biopsies
of prostate tissue were minced; tissue fragments were plated on Primaria
plates (Falcon); and HPE cells were cultured in epithelial cellselective
medium (RPMI 1640 supplemented with 2.5% charcoal-stripped, heatinactivated fetal bovine serum; 20 mmol/L HEPES buffer; 100 units/mL
penicillin; 100 mg/mL streptomycin; 0.25 mg/mL amphotericin B; 50 mg/mL
gentamicin; 56 mg/mL bovine pituitary extract; 1 insulin-transferrinselenium; 10 ng/mL epidermal growth factor; and 50 ng/mL cholera toxin)
and maintained in 5% CO2 at 37jC.
The parental HPET cell line was established by transducing HPE cells
(passage 2) with supernatant containing pLenti-hTERT-EGFP particles and
culturing them in selection medium containing 10 Ag/mL blasticidin. The
HPET-1, HPET-5, HPET-11, and HPET-13 clonal lines were established by
serial dilution and verified visually by at least two individuals. Telomerase
activity was determined as described (see Fig. 1C; ref. 13).
Anchorage-independent growth assays. Clonogenicity generation
assay were done as previously described with minor modifications (14).
Briefly, subconfluent cultures were harvested and plated in triplicate 35-mm
wells of six-well plates in 2 mL medium with 0.5% low gelling temperature
agarose at a concentration of 5 103 cells per mL on a 2-mL base layer of
1.0% agarose in medium. Cells were fed additional medium weekly. After
4 weeks, colonies with >40 cells were counted under an optical microscope.
For spheroid generation assay, cells were plated on ultralow adhesion tissue
culture dishes (Corning) at the density of 2 104 per mL in epithelial cell
selective medium without serum. Pictures were taken at 3 days after plating.
Cell differentiation on Matrigel. HPET and HPET1 cells were
trypsinized, and 2.5 105 cells were mixed in 50 AL of 50% (v/v) epithelial
medium and Matrigel (BD Biosciences; ref. 15). The mixture solidified in a
six-well Petri dish at 37jC and then detached from the dish. Four milliliters
of epithelial medium were added.
Immunofluorescence microscopy. Primary cultured cells were harvested by trypsinization and attached onto glass slides (VWR) by incubation
at 37jC overnight. Slides were fixed in 4% paraformaldehyde in PBS for
15 min, washed thrice in PBS, and permeabilized for 5 min on ice in PBS +
0.1% Triton X-100. Slides were blocked in PBS + 3% bovine serum albumin +
3% donkey serum for 30 min at room temperature. The slides were incubated
with primary antibodies for 1 h at room temperature and subsequently
incubated with Alexa Fluor 594 and/or Alexa Fluor 488conjugated
secondary antibody (Molecular Probes) for 1 h at room temperature. Then,
cells were washed in PBS and mounted using Vectashield mounting medium
containing 4,6-diamidino-2-phenylindole to counterstain nuclei (Vector
Laboratories). Images were captured with a Leica fluorescence microscope
equipped with a digital camera (Vanderbilt University Medical Center
Immunohistochemistry Core Laboratory). To show specificity of staining, the
following controls were included: omission of either the primary antibody or
the secondary antibodies.
Reverse transcription-PCR. Total cellular RNA from HPET, HPET-1,
HPET-5, HPET-11, HPET-13, and LNCaP cell lines was extracted using TRI
Reagent (Sigma) according to the manufacturers instructions. Two micrograms of total RNA for all cell lines were used to generate cDNA (RT-PCR
Access System, Promega). cDNA was amplified using 1 AL of the reverse
transcriptase reaction products in 25 AL with 10 pmol of the primers for
35 cycles. The PCR products were analyzed by electrophoresis on 1.5%
agarose gels. Primers are listed in Supplementary Table S1. Glyceraldehyde3-phosphate dehydrogenase was used as the internal control in all reactions.
Western blot analysis. Cells were extracted with ice-cold 1 lysis buffer
(Promega) and a cocktail of protease and phosphatase inhibitors (Sigma).
Lysates were then centrifuged for 10 min at 14,000 g at 4jC; 20 Ag protein
from each supernatant was subjected to 4% to 20% SDS-PAGE and
transferred to polyvinylidene difluoride and blocked and probed overnight
Results
hTERT overexpression immortalizes HPE cells. To immortalize HPE cells, we cultured primary HPE cells from human Gleason
grade 8 to 9 prostate cancer specimens under conditions favoring
epithelial cell growth (12). HPE cells (passage 2) were transduced
with pLenti-hTERT-EGFP particles and cultured in selection
medium containing 10 Ag/mL blasticidin to establish the parental
hTERT-expressing (HPET) cell line. HPE cells expressing hTERT
and GFP (labeled as HPET cells) were already evident after 1 week
in selection medium containing 10 Ag/mL blasticidin (Fig. 1A and
B). They grew as adherent cells with epithelial cell morphology
(Fig. 1D). HPET cells have successfully been cultured over a 1-year
period with no evidence of decreased proliferative capacity. The
original HPE cell culture exhibited measurable telomerase activity,
and this activity was increased in hTERT-immortalized parental
HPET and clonal HPET-1, HPET-5, HPET-11, and HPET-13 cell lines
(Fig. 1C). The levels of hTERT activity in the parental HPET and
clonal cells lines seemed indistinguishable. Clonally derived HPET
cell lines were established by serial dilution. Six 96-well plates were
seeded at one to a few cells per well, and 55 wells contained single
cells. Despite increased hTERT expression, only four single cell
clones (labeled HPET-1, HPET-5, and HPET-11 and HPET-13)
survived and expanded to over one million cells. These clonally
derived cells exhibited typical cobblestone morphology seen in
epithelial cell cultures (Fig. 1D). All remaining clones and single
cells underwent senescence within 4 to 6 weeks.
Parental HPET and clonal HPET cells do not express AR or
p63. In agreement with previous reports on putative prostate
stem/progenitor cells (17, 18), parental and clonal HPET cells do
not express AR protein (Fig. 2A and B), or secretory proteins such
as prostate-specific antigen (PSA) and PAP (data not shown). AR is
not observed even when cells are cultured in the presence of
androgen (data not shown). Data obtained from HPET-5 cells are
representative of that observed in the HPET-1, HPET-5, HPET-11,
4808
www.aacrjournals.org
Figure 1. Generation of the HPET and HPET-5 cell lines. A, primary HPE cells infected with virus. B, confirmation of transduction using GFP expression.
C, telomerase activity in cell lysates from parental HPET cells; clonal HPET-1, HPET-5, HPET-11, and HPET-13 cells; and original non-immortalized HPE cells.
Cells were analyzed for telomerase activity by TRAP assay according to the manufacturers instructions (TRAPeze, Chemicon). Telomerase activity was assayed from
2 Ag of cell extract including telomerase-positive control cells provided in the TRAPeze kit. Lysis buffer alone and 2 Ag of protein extract derived from all samples
was heat treated at 85jC for 5 min (which inactivates telomerase) and were used as negative controls. TSR8 DNA template provided in the TRAPeze kit served as
a PCR-positive control. D, representative micrographs of established parental HPET and clonal HPET-1, HPET-5, HPET-11, and HPET-13 cell lines as indicated.
Bar, 50 Am.
and HPET-13 clonal lines. Less than 1% HPET cells express minimal
levels of the basal cell marker p63, whereas p63 is absent in the
clonal HPET cell lines (Fig. 2A). CK8 and CK18 are expressed at low
levels in a small number of HPET and HPET-5 cells, indicating
limited luminal differentiation in culture. Together, these findings
suggest that HPET and HPET-5 cells are not derived from a p63expressing basal cell.
In contrast to previous reports on putative mammary and
prostate stem cells (17), we do not observe Hoechst 33342 dye
exclusion in either parental or clonal HPET cells (data not shown).
This supports a recent report on the generation of a functional
mammary gland from a single stem cell (19), suggesting that
Hoechst 33342 dye exclusion is not representative of all stem/
progenitor cells. HPET and clonal HPET cells were subsequently
screened with a panel of stem cell markers to determine their
molecular profile.
Parental HPET and clonal HPET-5 cells express embryonic
stem cell and early progenitor cell markers and exhibit other
stem celllike properties. As anticipated, expression levels of
embryonic stem cell and prostate progenitor markers varied
between the parental and clonal HPET cell lines because they
were derived from different clones (Fig. 2BD). However, all lines
express mRNA for the embryonic stem cell markers Nanog, Oct4,
and Sox2 that regulate pluripotency and self-renewal in mouse
www.aacrjournals.org
4809
Cancer Research
and B). HPET cells form tumors in 3 months with an average size of
6 6 3 mm. The human origin of the tumor is confirmed by GFP
staining and human-specific mitochondrial protein hMT (28)
expression (Fig. 4C). Importantly, histopathologic and immunohistochemical analyses indicate that HPET tumors are nearly identical
to the original human prostate cancer biopsy from which they were
derived (Fig. 5A and Fig. 6A). They show typical heterogeneity
observed in human prostate cancer and are classified as Gleason
4 + 4. Gleason 5 patterns like those observed in the original tumor
(Gleason 5 + 4) are also present (Fig. 6A).
Immunohistochemical analysis indicates that AR is reexpressed in most cells, although some tumor foci are AR ,
similar to that observed in advanced prostate adenocarcinomas
(29). HPET tumors also re-express the differentiated protein PAP,
although PSA was not observed (data not shown). All tumors
exhibit a high proliferative index as seen by Ki67 staining.
Significantly, the three prostate epithelial cell lineages are
represented (Fig. 5A and D). Luminal epithelial cells are identified
by their high levels of E-cadherin and CK8/18 expression. In
regions where cribriform high-grade prostatic intraepithelial
4810
www.aacrjournals.org
Figure 3. Characterization
of the progenitor capacity of
(AR )p63 CD44+Nestin+ HPET and
HPET-5 cells in vitro. A, multicellular
spheroid formation on lowadherence culture plates. Bar, 50 Am.
B, colonies and branching structures of
(AR )p63 CD44+Nestin+ HPET and
HPET-5 cells on Matrigel. Representative
H&E-stained sections (bottom ). Bar ,
200 Am (top ) and 20 Am (bottom ).
C, colony-forming ability on agar. Bar,
100 Am. D, histogram of Fig. 2C. Columns,
mean (n = 3); bars, SE.
recapitulate the histopathology of the original prostate adenocarcinoma in vivo and differentiate into the three prostate epithelial
cell lineages in vivo (Fig. 5B). Thus, it seems that these three cell
lineages arise from a common (AR )p63 CD44+Nestin+ stem/
progenitor cell.
Within most tumors, there likely exists a subpopulation of cancer
stem cells that continue to potentiate tumorigenesis. As seen in
Fig. 5C, CD44 expression occurs at the cell membrane in both basal
and luminal-like cells. Nestin expression is observed in a few cells
within the basal and luminal cell compartments, suggesting that
prostate cancer stem/progenitor cells are not restricted to the basal
cell compartment. These findings concur with the observation that
slow-cycling/stem cells are present in both basal and luminal cell
compartments (10). Serial transplantation experiments were done
www.aacrjournals.org
4811
Cancer Research
Figure 5. (AR )p63 CD44+Nestin+ HPET-5 cells differentiate into the epithelial cell lineages of the prostate and recapitulate the original human tumor (HT ). A, similar
to that of the original HT specimen, epithelial cells in HPET and HPET-5 tumors re-expressed AR and PAP. The high proliferative index in the human tumor
(as seen by antiKi-67 staining) was reproduced in HPET and HPET-5 tumors. Bar, 50 Am. B, epithelial cell differentiation in tumors derived from single-cell origin
(AR )p63 CD44+Nestin+ HPET-5 cells. Staining with anti-CK8/18 and anti-E-cadherin antibodies identified luminal epithelial cells. p63- and 34hE12-positive cells
depicted basal epithelial cells surrounding glandular structures. Prostate tumors often express neuroendocrine factors such as synaptophysin (Syn ). HPET and HPET-5
cells expressing synaptophysin were also observed. Bar, 50 Am. C, identification of cells that retain CD44 and Nestin expression. Both stem/progenitor cell markers
were expressed in the human tumor and HPET and HPET-5 tumors. Bar, 50 Am. Inserts highlight their staining pattern. Bar, 10 Am. D, diagrammatic summary of
the immunohistochemical analyses representing the differentiation of HPET and HPET-5 cells to luminal cells, basal cells, and neuroendocrine cells.
Discussion
Similar to normal organs arising from normal stem cells, tumors
could be viewed as aberrant organs composed of heterogeneous
cell populations arising from cancer cells that have acquired the
capability for indefinite proliferation (1). Indeed, the clonal origin
of many tumors suggests that tumorigenic cells undergo processes
analogous to self-renewal and differentiation, generating self-
4812
www.aacrjournals.org
(31) showed that with the introduction of AR, HPE cell (PrEC) lines
immortalized with hTERT and transformed by SV40 large/small
T antigen (PrEC LHS-AR) or H-ras (PrEC LHSR-AR) underwent
partial differentiation into a luminal phenotype in vitro and in vivo.
In a different study, HPE cells immortalized with hTERT
differentiated into glandular buds in three-dimensional culture
on Matrigel (32). These structures consisted of a peripheral layer of
p63-positive cells surrounding luminal cells expressing low levels of
AR and PSA (32).
The origin of the prostate stem cell is still under debate. The p63
null mouse model (33, 34) suggests that epithelial development
does not occur in the absence of p63, which is highly expressed in
basal or progenitor layers of many epithelial tissues (35). However,
prostatic buds only appear on embryonic day 17.5 and are
underdeveloped at the time p63 / mice die perinatally. Signoretti
and Loda show that the whole prostatic epithelium is derived from
p63+ ROSA26 embryonic stem cells injected into p63 / blastocysts
in blastocyst complementation experiments (36). In contrast, using
renal grafting to rescue p63 / urogenital sinus and allow
differentiation, Kurita et al. show that in the absence of p63expressing basal cells, luminal secretory and neuroendocrine
epithelial cells still develop and are able to regenerate after
castration (37). In our study, clonal HPET-5 cells do not express
Figure 6. Histopathologic comparison of the original human tumor specimen with HPET and HPET-5 tumor grafts. A, a, original human tumor specimen. H&E
section of a radical prostatectomy whole-mount human specimen showing prostatic adenocarcinoma (Gleason grade 5 + 4 = 9) with neuroendocrine features. Within
the higher Gleason pattern, there are nuclei with "salt and pepper" chromatin and lack of prominent nucleoli suggestive of neuroendocrine differentiation. No
lymphovascular invasion is identified within these whole mount sections. b, human tumor containing Gleason pattern 4. c, HPET tumor graft. Prostatic adenocarcinoma
Gleason score 4 + 4 = 8 with abundant mitotic figures and apoptotic bodies. This tumor has abundant cribriforming patterns with salt and pepper nuclei similar to
the human tumor with a paucity of prominent nucleoli. There are focal areas of marked nuclear atypia that are also found in the human tumor. Sparse stroma is present
around glands with small, thin-walled vessels within stroma. d, small HPET focus containing Gleason pattern 5 (white arrow ). e, HPET-5 tumor graft. Prostatic
adenocarcinoma, Gleason grade 4 + 4 = 8 with neuroendocrine features, abundant mitotic figures and apoptosis. No Gleason pattern 5 is found. There is cytologic
atypia and sparse stroma around glands with small, thin-walled vessels within stroma. Bar , 50 Am. B, HPET and HPET-5 tumors are regenerated upon serial
transplantation. Serial transplantation was carried out by combining a small fragment of HPET or HPET-5 tumor tissue from the original graft with embryonic rUGM and
grafting them under the kidney capsule of SCID mice. Histologically, the regenerated tumors recapitulated the original tumors and retained small subpopulations of
cells expressing CD44 and Nestin. Bar , 50 Am.
www.aacrjournals.org
4813
Cancer Research
References
1. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem
cells, cancer, and cancer stem cells. Nature 2001;414:
10511.
2. Sell S, Pierce GB. Maturation arrest of stem cell
differentiation is a common pathway for the cellular
origin of teratocarcinomas and epithelial cancers. Lab
Invest 1994;70:622.
3. Roy NS, Nakano T, Keyoung HM, et al. Telomerase
immortalization of neuronally restricted progenitor cells
derived from the human fetal spinal cord. Nat
Biotechnol 2004;22:297305.
4. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay
JW. Telomerase activity in human germline and
embryonic tissues and cells. Dev Genet 1996;18:1739.
5. Ostenfeld T, Caldwell MA, Prowse KR, Linskens MH,
Jauniaux E, Svendsen CN. Human neural precursor cells
express low levels of telomerase in vitro and show
diminishing cell proliferation with extensive axonal
outgrowth following transplantation. Exp Neurol 2000;
164:21526.
6. Yasunaga Y, Nakamura K, Ko D, et al. A novel human
cancer culture model for the study of prostate cancer.
Oncogene 2001;20:803641.
7. Yasunaga Y, Nakamura K, Ewing CM, Isaacs WB,
Hukku B, Rhim JS. A novel human cell culture model for
tissues such as the ovary (46). Interestingly, Sox2 seems to bind the
promoter of the Nestin gene to regulate its expression in neural
primordium (47). However, Nestin is not restricted to neural stem
cells, being expressed in embryonic stemderived progenitor cells
that can develop into neuroectodermal, endodermal, and mesodermal lineages (26). Prostate cancer stem cells seem to express
CD133 (30). CD133, initially isolated from neuroepithelial cells, is
also found in hematopoietic and endothelial progenitor cells (48). An
intriguing hypothesis is that neural crest is the source of all adult
stem cells in peripheral tissues (49), and that differentiation across
germ layers to many organs depends upon microenvironment (50).
Although HPET cells express Nestin and CD133, it is uncertain
whether prostatic HPET cells originate from neural crest.
The clonal HPET cancer stem/progenitor cell lines with
embryonic stem cell and early progenitor cell characteristics
provide the first in vivo model that recapitulates the original
Gleason score of the tumor from which they were derived. Thus,
this model may enhance our understanding of human tumor
development and provide a mechanism for preclinical testing of
diagnostic, treatment, and prevention strategies for cancer
patients. Furthermore, they provide cell lines critical to performing
in-depth mechanistic studies on the function of cancer stem cells
and epithelial cell differentiation. Because many epithelial cancers
seem to arise from cancer stem cells and often exhibit similar
characteristics, knowledge generated by the HPET cell lines will
likely be applicable to other epithelial cancers.
Acknowledgments
Received 12/21/2006; revised 3/6/2007; accepted 3/14/2007.
Grant support: National Institute of Diabetes and Digestive and Kidney Diseases
grants R01 DK60957 and R01 DK059142 and Frances Williams Preston Laboratories of
the T.J. Martell Foundation (S. Kasper).
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked advertisement in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
We thank Dr. Karin Williams for subcloning the EGFP gene into the Lentiviral
vector, Dr. Judith Campisi for providing the pBABE-PURO-hTERT vector, Anthony
Frazier for sectioning the human prostate whole mounts, and Erin Tillman for
proofreading the manuscript.
4814
www.aacrjournals.org
www.aacrjournals.org
4815